IRLAB Therapeutics AB ser. A (SE0012675361) — research page
SE · se-cm-kg/XSTO/SE0012675361 · as of 2026-11-06
Identity and listing
The issuer is IRLAB Therapeutics AB ser. A, listed on Nasdaq Stockholm under ticker SE0012675361, with ISIN SE0012675361 and LEI 549300JAT34LHEI0DH60. Its security type, segment, sector and jurisdiction are not on the record. Its status is listed, not halted.
| field | value | source · read date |
|---|---|---|
| name | IRLAB Therapeutics AB ser. A | source · 2026-11-06 |
| exchange | Nasdaq Stockholm | source · 2026-11-06 |
| ticker | SE0012675361 | source · 2026-11-06 |
| ISIN | SE0012675361 | source · 2026-11-06 |
| LEI | 549300JAT34LHEI0DH60 | source · 2026-11-09 |
| security type | not on the record | |
| segment | not on the record | |
| sector | not on the record | |
| jurisdiction | not on the record | |
| status | listed, not halted | source · 2026-11-09 |
The disclosure read
The record holds 40 filings across 37 filing days in the window 2025-11-06 to 2026-11-06. The median gap between filing days is 7.5 days. The latest filing is dated 2026-11-06 and is of type Investor News, 0 days before the record date of 2026-11-06. Nasdaq Stockholm has 398 issuers with a median of 30.0 filings, a median cadence gap of 9.5 days and a median latency of 7.0 days. The sector median is not on the record.
| filings | median gap between filing days | days from latest filing to as-of | |
|---|---|---|---|
| this issuer | 40 | 7.5 | 0 |
| exchange median: Nasdaq Stockholm (398 issuers) | 30 | 9.5 | 7 |
| date | type | category | filing |
|---|---|---|---|
| 2026-11-06 | Investor News | Investor News | IRLAB: Invitation to the interim report for Q3 2026 presentation and webcast |
| 2026-10-27 | Investor News | Investor News | The U.S. Patent and Trademark Office has issued a Notice of Allowance for a patent covering IRLAB's drug candidate IRL1117 |
| 2026-10-20 | Other information disclosed according to the rules of the Exchange | Other information disclosed according to the rules of the Exchange | Nomination committee appointed for IRLAB's annual general meeting 2027 |
| 2026-10-20 | Investor News | Investor News | IRLAB's Preclinical Research Underpinning Linepemat Published in Peer-Reviewed Journal |
| 2026-10-09 | Investor News | Investor News | IRLAB to present at Redeye Theme: Neurology |
window 2025-11-06 to 2026-11-06 · the node's disclosure lines, as get_filings serves them
Auditor
The auditor and its location are not on the record. Auditor changes are not on the record, as this register has no lifecycle type map yet.
Events and halts
Listing, delisting, name change, domicile change and segment move are not on the record, as this register has no lifecycle type map yet. The halt flag shows the issuer as listed, not halted.
Orderability
The outcome is not determinable, because the chapter's orderability section carries no client categories and so the outcome cannot name its client category. The rule version is acm-68000/se/mifid-ii-product-governance/r1, with the chapter as of 2026-11-04.
rule acm-68000/se/mifid-ii-product-governance/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability
Coverage
The record holds one research house named on the issuer's investor-relations page, Redeye.
| research house | analyst | source · read date |
|---|---|---|
| Redeye | issuer page · 2026-11-12 |
Open research
No openly published research notes were found on the record.
Licensed
Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.
| licensor | entitlement | title | date | source |
|---|---|---|---|---|
| none loaded |
As-of depth
The market's vintage is not sealed. No issuer years are sealed, and the earliest sealed date of the market and the date the live record began are not on the record.
Sources
7 source pages are named on this page; every value above carries its own source page and read date in the numbers.
- 10.1
- https://firds.esma.europa.eu/firds/ (identity.exchange)
- 10.2
- https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)
- 10.3
- https://mcp.se-cm-kg.ai/events/XSTO/SE0012675361 (the disclosure lines)
- 10.4
- https://api.news.eu.nasdaq.com/news/query.action?globalGroup=exchangeNotice&globalName=ExchangenewsFilter|FirstNorthInformation (the halt flag)
- 10.5
- https://se.eu-cm-kg.ai/book/aio.json (the orderability chapter)
- 10.6
- https://irlab.se/investor-relations/ (coverage)
- 10.7
- https://mcp.se-cm-kg.ai/record/XSTO/SE0012675361 (the record)
Read it by agent
The same page, signed and receipted: get_research at https://mcp.getresearch.ai/mcp with {"isin":"SE0012675361"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:7bc5f8e98c848164.